GE HealthCare Technologies (GEHC) shares gained Wednesday after Jefferies analysts called the stock a “franchise pick” and made a bullish case for the company’s diagnostic imaging business.
Jefferies bumped its rating for the stock up to “buy” from “hold,” and raised its price target to $103 from $95, bringing it above the broader analyst consensus compiled by Visible Alpha at about $95. Shares rose 3.5% to close at $86.26 Wednesday and have added about 13% over the past year.
The analysts said the firm holds a leading position in the diagnostic imaging market, which they expect to grow by mid-single digits. GE HealthCare could also benefit from market consolidation, they noted.
Jefferies added that improving business in China "could be another icing on the cake.” China makes up 12% of the company’s sales, and GE HealthCare said in October that macroeconomic weakness in the country negatively impacted third-quarter sales.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.